This Charles Schwab Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• HC Wainwright & Co. analyst Mitchell Kapoor upgraded the rating for Sarepta Therapeutics, Inc. SRPT from Sell to Neutral and maintained the price target of $75. Sarepta Therapeutics shares closed at $61.91 on Tuesday. See how other analysts view this stock.
• JP Morgan analyst Jimmy Bhullar upgraded Reinsurance Group of America, Incorporated RGA from Neutral to Overweight and raised the price target from $232 to $237. Reinsurance Group shares closed at $198.27 on Tuesday. See how other analysts view this stock.
• Citigroup analyst Christopher Allen upgraded the rating for The Charles Schwab Corporation SCHW from Neutral to Buy and lifted the price target from $85 to $102. Charles Schwab shares closed at $77.67 on Tuesday. See how other analysts view this stock.
• Goldman Sachs analyst Will Nance upgraded Fiserv, Inc. FI from Neutral to Buy and raised the price target from $246 to $260. Fiserv shares closed at $222.01 on Tuesday. See how other analysts view this stock.
• Truist Securities analyst Bill Chappell upgraded The Scotts Miracle-Gro Company SMG from Hold to Buy and maintained the price target of $70. Scotts Miracle Gro shares closed at $54.77 on Tuesday.  See how other analysts view this stock.

Considering buying SCHW stock? Here’s what analysts think:

Read This Next:

• How To Earn $500 A Month From Conagra Brands Stock Ahead Of Q3 Earnings

Photo via Shutterstock